Episode 9: Mounjaro Tomorrow, the future of medical obesity treatment? episode artwork

EPISODE · May 31, 2023 · 1H 29M

Episode 9: Mounjaro Tomorrow, the future of medical obesity treatment?

from The Plus SideZ: A GLP-1 Guide to Metabolic Health · host Kim Carlos

Resources for the Community:___________________________________________________________________Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Ro GLP-1 Insurance Checker https://ro.co/weight-loss/glp1-insurance-checker/Ro GLP-1 Supply and Shortage Tracker https://ro.co/weight-loss/supply-tracker/Learn more about Obesity https://www.obesityaction.org/ ______________________________________________________________________Today, we discuss the GLP-1 GIP medication, Mounjaro, and debate if we think it's the future of obesity treatment. We are joined by our GLP-1 TikTok community guest, Beth, who shares her story and struggles with obesity, PCOS, infertility, and insulin resistance. Beth learned about Mounjaro while exploring her options for gastric sleeve surgery and it's changed her life in so many ways. Our medical specialist this week is Alex Guevara, an Advanced Practice Provider in Primary Care in the UK, specializing in medical weight loss using GLP-1 therapies. He has been at the forefront of GLP-1 information and education for the last few years on social media and manages the World’s largest Facebook education groups for those using GLP-1 therapies. Alex also provides guidance and training on medical weight loss for providers both in the UK and the U.S. In addition, he is an avid campaigner against obesity stigma and appears regularly on national press and TV to provide education and expert commentary on medical weight loss. Check out Beth’s special Mounjaro Women's 6 Month Weight Loss Journal: Motivational Diet and Exercise Planner | Weekly Shot & Symptom Tracker for GLP-1 Medications https://amzn.to/3q8zEBCAlex’s Facebook support groups are: Mounjaro Weight Loss Success Ozempic / Wegovy Weight Loss Support Group______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter,  Producer TikTokInstagram 

Episode metadata supplied by the publisher feed · Published May 31, 2023

Embed this episode

Resources for the Community: ___________________________________________________________________ Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55 Ro GLP-1 Insurance Checker https://ro.co/weight-loss/glp1-insurance-checker/ Ro GLP-1 Supply and Shortage Tracker https://ro.co/weight-loss/supply-tracker/ Learn more about Obesity https://www.o...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Episode 9: Mounjaro Tomorrow, the future of medical obesity treatment?

0:00 1:29:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Plus SideZ: A GLP-1 Guide to Metabolic Health?

This episode is 1 hour and 29 minutes long.

When was this The Plus SideZ: A GLP-1 Guide to Metabolic Health episode published?

This episode was published on May 31, 2023.

Can I download this The Plus SideZ: A GLP-1 Guide to Metabolic Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!